The National Institutes of Health (NIH) is offering funding for Phased Innovation (R21/R33) projects to investigate the effects of reducing illicit drug use on health and functional outcomes in individuals with substance use disorders. This grant supports up to two years of research planning and feasibility studies (R21 phase), with the potential for additional funding based on successful milestones for expanded research (R33 phase). The goal is to generate evidence that demonstrates the benefit of reducing illicit drug use as a valid outcome measure in clinical trials for pharmacotherapies treating substance use disorders. Closing date for applications is January 7, 2018.
Opportunity ID: 271929
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PA-15-099 |
Funding Opportunity Title: | Reductions in Illicit Drug Use and Functional Outcomes (R21/R33) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Jan 23, 2015 |
Last Updated Date: | Apr 12, 2017 |
Original Closing Date for Applications: | Sep 07, 2017 |
Current Closing Date for Applications: | Jan 07, 2018 |
Archive Date: | Feb 06, 2018 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Public housing authorities/Indian housing authorities Independent school districts For profit organizations other than small businesses Native American tribal governments (Federally recognized) County governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Private institutions of higher education Special district governments City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications for Phased Innovation (R21/R33) projects to determine whether reductions in illicit drug use are associated with positive changes in health-related and other functional outcomes in individuals with substance use disorders (SUDs). Functional outcomes include, for example, reductions in morbidity, mortality, criminal justice involvement, overall healthcare expenditures. This FOA provides support for up to two years (R21 phase) for research planning activities and feasibility studies, followed by possible transition to expanded research support (R33 phase). The transition to the R33 phase will be determined by NIH program evaluation of successful achievement of the milestones set for the R21 phase. The ultimate goal of this FOA is to provide evidence that will enable regulatory authorities to accept reductions in illicit drug use as a valid outcome measure in clinical trials of pharmacotherapies for the treatment of SUDs. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-15-099.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Updated expiration date in accordance with NOT-DA-17-023 | Apr 12, 2017 | |
Apr 12, 2017 |
DISPLAYING: Synopsis 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PA-15-099 |
Funding Opportunity Title: | Reductions in Illicit Drug Use and Functional Outcomes (R21/R33) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Jan 23, 2015 |
Last Updated Date: | Apr 12, 2017 |
Original Closing Date for Applications: | Sep 07, 2017 |
Current Closing Date for Applications: | Jan 07, 2018 |
Archive Date: | Feb 06, 2018 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Public housing authorities/Indian housing authorities Independent school districts For profit organizations other than small businesses Native American tribal governments (Federally recognized) County governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Private institutions of higher education Special district governments City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications for Phased Innovation (R21/R33) projects to determine whether reductions in illicit drug use are associated with positive changes in health-related and other functional outcomes in individuals with substance use disorders (SUDs). Functional outcomes include, for example, reductions in morbidity, mortality, criminal justice involvement, overall healthcare expenditures. This FOA provides support for up to two years (R21 phase) for research planning activities and feasibility studies, followed by possible transition to expanded research support (R33 phase). The transition to the R33 phase will be determined by NIH program evaluation of successful achievement of the milestones set for the R21 phase. The ultimate goal of this FOA is to provide evidence that will enable regulatory authorities to accept reductions in illicit drug use as a valid outcome measure in clinical trials of pharmacotherapies for the treatment of SUDs. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-15-099.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PA-15-099 |
Funding Opportunity Title: | Reductions in Illicit Drug Use and Functional Outcomes (R21/R33) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Apr 12, 2017 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Sep 07, 2017 |
Archive Date: | Oct 08, 2017 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | County governments Small businesses State governments Public housing authorities/Indian housing authorities For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Private institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications for Phased Innovation (R21/R33) projects to determine whether reductions in illicit drug use are associated with positive changes in health-related and other functional outcomes in individuals with substance use disorders (SUDs). Functional outcomes include, for example, reductions in morbidity, mortality, criminal justice involvement, overall healthcare expenditures. This FOA provides support for up to two years (R21 phase) for research planning activities and feasibility studies, followed by possible transition to expanded research support (R33 phase). The transition to the R33 phase will be determined by NIH program evaluation of successful achievement of the milestones set for the R21 phase. The ultimate goal of this FOA is to provide evidence that will enable regulatory authorities to accept reductions in illicit drug use as a valid outcome measure in clinical trials of pharmacotherapies for the treatment of SUDs. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-15-099.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-C | FORMS-C | PKG00212183 | May 16, 2015 | May 07, 2016 | View | |
FORMS-D | Use for due dates on or after May 25, 2016 | PKG00222690 | May 16, 2016 | Jan 07, 2018 | View |
Package 1
Mandatory forms
271929 RR_SF424_2_0-2.0.pdf
271929 PHS398_ResearchPlan_2_0-2.0.pdf
271929 PHS398_CoverPageSupplement_2_0-2.0.pdf
271929 RR_Budget_1_3-1.3.pdf
271929 RR_KeyPersonExpanded_2_0-2.0.pdf
271929 RR_OtherProjectInfo_1_3-1.3.pdf
271929 PerformanceSite_2_0-2.0.pdf
Optional forms
271929 PlannedReport-1.0.pdf
271929 PHS398_CumulativeInclusionReport-1.0.pdf
271929 RR_SubawardBudget30_1_3-1.3.pdf
Package 2
Mandatory forms
271929 RR_SF424_2_0-2.0.pdf
271929 PHS398_CoverPageSupplement_3_0-3.0.pdf
271929 RR_OtherProjectInfo_1_3-1.3.pdf
271929 PerformanceSite_2_0-2.0.pdf
271929 RR_KeyPersonExpanded_2_0-2.0.pdf
271929 RR_Budget_1_3-1.3.pdf
271929 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
271929 RR_SubawardBudget30_1_3-1.3.pdf
271929 PHS_Inclusion_Enrollment_Report-1.0.pdf
271929 PHS_AssignmentRequestForm-1.0.pdf